How Cannabis Relieves Chronic Pain
Cannabinoids interact with CB1 and CB2 receptors distributed throughout the peripheral and central nervous systems. THC activates CB1 receptors in pain-processing regions including the periaqueductal grey matter, reducing pain signal transmission. CBD modulates TRPV1 pain receptors and has significant anti-inflammatory effects via CB2 receptors in immune cells. The terpene myrcene has demonstrated additional analgesic properties that enhance the entourage effect. Strains like Harlequin (high CBD) are popular for daytime pain management, while OG Kush is widely reported for evening pain relief. Understanding cannabis pain relief effects helps patients select the most appropriate approach.
Clinical Evidence & Research
A comprehensive 2017 National Academies of Sciences report concluded there is conclusive evidence that cannabis is effective for treatment of chronic pain in adults. Multiple randomised controlled trials have demonstrated significant pain reduction versus placebo. A large Canadian observational study of 1,000+ chronic pain patients found 73% reported significant pain reduction after 12 months of medical cannabis use, with notable reductions in opioid consumption. Germany approved medical cannabis specifically for chronic pain in 2017, with the Netherlands and several other EU nations following.
Access & Patient Requirements
Chronic pain is the most widely accepted qualifying condition for medical cannabis in the US, recognised in all 40+ medical states. California, Colorado, and New York all have broad chronic pain qualifying criteria. Patients typically need documented pain lasting 3+ months, plus an evaluation by a cannabis-certified physician. Many states accept prior opioid prescriptions as supporting evidence, as cannabis is increasingly used as an opioid-sparing therapy.
Recommended Cannabis Approaches for Chronic Pain
Daytime pain management typically uses CBD-dominant or balanced CBD:THC products to avoid cognitive impairment. Evening or severe pain episodes may warrant higher-THC products. Topical cannabis preparations are effective for localised musculoskeletal pain without systemic effects. Vaporised cannabis offers rapid onset (2-5 minutes) for breakthrough pain. CBD and THC work synergistically for pain, and anti-inflammatory effects contribute significantly in conditions like arthritis and fibromyalgia. The terpene beta-caryophyllene acts as a CB2 agonist and adds meaningful analgesic benefit.